Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$192M |
| 2 |
Johnson & Johnson
JNJ
|
+$179M |
| 3 |
EMC
EMC CORPORATION
EMC
|
+$177M |
| 4 |
Chubb
CB
|
+$153M |
| 5 |
Eli Lilly
LLY
|
+$142M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$470M |
| 2 |
PRE
PARTNERRE LTD
PRE
|
+$186M |
| 3 |
Comcast
CMCSA
|
+$179M |
| 4 |
Pfizer
PFE
|
+$168M |
| 5 |
Gilead Sciences
GILD
|
+$144M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.85% |
| 2 | Technology | 12.31% |
| 3 | Financials | 12.27% |
| 4 | Industrials | 10.64% |
| 5 | Consumer Staples | 10.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CIVI
2701
DELISTED
Civitas Solutions, Inc.
CIVI
| $762K | ﹤0.01% |
43,703
+26,603
| +156% | +$548K |
|
2702
DMC Global
BOOM
$155M
| $761K | ﹤0.01% |
117,500
-9,900
| -8% | -$60.5K |
|
|
FWDI
2703
Forward Industries Inc
FWDI
$305M
| $759K | ﹤0.01% |
58,870
+830
| +1% | +$11K |
|
2704
State Street Health Care Select Sector SPDR ETF
XLV
$44B
| $759K | ﹤0.01% |
11,200
-42,300
| -79% | -$2.83M |
|
2705
First Horizon
FHN
$12.3B
| $758K | ﹤0.01% |
+57,900
| New | +$738K |
|
2706
Lear
LEA
$8.16B
| $756K | ﹤0.01% |
+6,800
| New | +$720K |
|
|
CPE
2707
DELISTED
Callon Petroleum Company
CPE
| $756K | ﹤0.01% |
+8,539
| New | +$594K |
|
|
CBR
2708
DELISTED
CIBER Inc.
CBR
| $756K | ﹤0.01% |
358,100
+87,500
| +32% | +$223K |
|
|
DRYS
2709
DELISTED
DryShips Inc. Common Stock
DRYS
| $753K | ﹤0.01% |
1
| – | – |
|
|
KIN
2710
DELISTED
Kindred Biosciences, Inc.
KIN
| $752K | ﹤0.01% |
217,900
-48,002
| -18% | -$170K |
|
2711
AMCON Distributing
DIT
$66.4M
| $751K | ﹤0.01% |
13,800
+150
| +1% | +$7.8K |
|
2712
Greif Class B
GEF.B
$4.24B
| $749K | ﹤0.01% |
16,000
+500
| +3% | +$19.4K |
|
2713
MiMedx Group
MDXG
$624M
| $747K | ﹤0.01% |
85,500
+65,900
| +336% | +$548K |
|
|
CTLP
2714
DELISTED
Cantaloupe
CTLP
| $743K | ﹤0.01% |
+170,300
| New | +$613K |
|
|
UBP
2715
DELISTED
Urstadt Biddle Properties Inc.
UBP
| $743K | ﹤0.01% |
41,100
+600
| +1% | +$10.8K |
|
|
BLT
2716
DELISTED
BLOUNT INTERNATIONAL (NEW)
BLT
| $743K | ﹤0.01% |
74,400
-267,300
| -78% | -$2.56M |
|
|
SALM
2717
DELISTED
Salem Media Group, Inc. Class A Common Stock
SALM
| $741K | ﹤0.01% |
128,600
+300
| +0.2% | +$1.37K |
|
|
COB
2718
DELISTED
CommunityOne Bancorp
COB
| $740K | ﹤0.01% |
55,700
+15,100
| +37% | +$195K |
|
|
NW.PRC.CL
2719
DELISTED
Natwest Bank Ads Series C
NW.PRC.CL
| $736K | ﹤0.01% |
28,500
+6,178
| +28% | +$158K |
|
2720
MediciNova
MNOV
$64.5M
| $735K | ﹤0.01% |
100,100
+1,900
| +2% | +$9.41K |
|
2721
Scully Royalty
SRL
$90.9M
| $733K | ﹤0.01% |
74,080
+11,020
| +17% | +$112K |
|
2722
LiveRamp
RAMP
$2.3B
| $730K | ﹤0.01% |
34,045
-19,500
| -36% | -$388K |
|
|
OXGN
2723
DELISTED
OXIGENE INC COM
OXGN
| $730K | ﹤0.01% |
919,100
+99,300
| +12% | +$62.5K |
|
|
SHYF
2724
DELISTED
The Shyft Group
SHYF
| $728K | ﹤0.01% |
184,200
+82,000
| +80% | +$271K |
|
|
GENE
2725
DELISTED
Genetic Technologies Ltd.
GENE
| $726K | ﹤0.01% |
15,719
-155
| -1% | -$6.75K |
|
Similar funds
Jim Simons's Q1 2016 Portfolio in Review
As of Q1 2016, Jim Simons held 3,753 positions worth $52.6B, up 15% from $45.9B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.31B of net new capital in Q1 2016, opening 498 new positions and adding to 2,018 existing holdings. Its largest new stake was EMC CORPORATION: 7,000,400 shares worth $187M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Pfizer, an estimated $168M trimmed.
- Jim Simons's largest Q1 2016 buy was EMC CORPORATION: 7,000,400 shares worth $187M.
- Jim Simons added most to PepsiCo in Q1 2016, an estimated $192M increase.
- Jim Simons's biggest Q1 2016 reduction was Pfizer, cutting an estimated $168M.
- Jim Simons fully exited Apple in Q1 2016, selling an estimated $470M.
- Jim Simons's ten largest holdings make up 7.9% of its $52.6B portfolio in Q1 2016.
- Jim Simons opened 498 new positions and closed 403 in Q1 2016.
- Jim Simons's portfolio value rose 15% quarter-over-quarter to $52.6B.
Based on Renaissance Technologies's 13F filing for Q1 2016, filed 13 May 2016.